Unraveling the Potential: Insights into Oncolytic Virus Therapy

Discover the transformative power of oncolytic virus therapy in cancer treatment. Stratview Research reveals that the Global Oncolytic Virus Therapy Market is set to surge from USD 101.2 million in 2020 to USD 356.7 million by 2026, boasting a staggering CAGR of over 23.7%. With North America leading the charge, this groundbreaking therapy offers new hope for patients worldwide. Delve into the world of oncolytic virus therapy to uncover its immense potential in revolutionizing cancer care and improving patient outcomes.